yup, probably picked up by his team and Berkshire Hathway’s only biotech buy so far .... and one of the non- performing one stocks in his portfolio
Biotech is high risk investment... 50:50 could go either way and he is known for safer investment and holding
Would you blindly hold a biotech even if they keep flipping negative results and unable to deliver a marketable product?
Anyway, its MSB thread not Berkshire Hathways or Biogen’s
Mesoblast Investor losses, page-73
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 274918 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 974 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |